A drop off in the number of commercially led trials has had an opportunity cost for UK taxpayers of an estimated £360 million over the past five years, says government commissioned review

Delays in getting the CE mark for medical devices are stretching the resources of European start-ups and forcing some to turn their attention to the US

The initiative is backed by over 1.2 million people - but science and academic groups warn it would be a devastating blow for EU health research. A ban ‘would endanger the lives of millions of people’ says one MEP

Long-awaited Commission proposals to reform EU’s pharmaceutical legislation seek to improve access to medicines and promote innovation, but companies say they will drive investment out of Europe

Already overdue, the new pharmaceutical strategy will not be published tomorrow as promised. The Commission says the proposal will arrive ‘slightly later’, as tensions fly high over how to incentivise industrial R&D

The EU has ambitions to set up a shared system giving researchers cross-border access to large amounts of health data. Parliament wants to make sure it’s trusted and robust

The latest figures on R&D funding for neglected diseases show the EU is making its greatest contribution to date. But looking at the big picture it’s clear more needs to be done to tackle diseases that affect millions of people around the world

Greater integration between research and technology transfer at Cancer Research UK is supporting the formation of more start-ups and fostering the development of an international network of academic partners with complementary skills and capabilities

As it gets easier to engineer deadly pathogens, the International Biosecurity and Biosafety Initiative for Science wants tighter controls on custom-order DNA companies, and an end to the current ‘checkbox’ approach to lab safety

Farrar will oversee science at the World Health Organisation, after leading Europe’s biggest medical research charity for nearly a decade